Şunu aradınız:: authorisation of the medicinal product (İngilizce - Estonca)

name of the medicinal product
ravimi nimetus

name of the medicinal product.
ravimi nimi.

components of the medicinal product
ravimi koostisosad

reporting suspected adverse reactions after authorisation of the medicinal product is important.
ravimi voimalikest korvaltoimetest on oluline teavitada ka parast ravimi muugiloa valjastamist.

reporting of suspected adverse reactions after authorisation of the medicinal product is important.
ravimi võimalikest kõrvaltoimetest on oluline teavitada ka pärast ravimi müügiloa väljastamist.

reporting of suspected adverse reactions that occur after authorisation of the medicinal product is important.
ravimi võimalikest kõrvaltoimetest on oluline teavitada ka pärast ravimi müügiloa väljastamist.

reporting of suspected adverse reactions after authorisation of the medicinal products is important.
ravimi võimalikest kõrvaltoimetest on oluline teavitada ka pärast ravimi müügiloa väljastamist.